MOONLAKE IMMUNOTHERAPEUTICS

Ticker: MLTX CUSIP: 61559X104 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 321,109 Value ($000) $2,302 Avg Close $52.12 Range $5.95 - $62.75
Q2 2025
Shares 529,211 Value ($000) $24,979 Avg Close $40.73 Range $31.42 - $52.88
Q1 2025
Shares 640,917 Value ($000) $25,041 Avg Close $43.09 Range $36.52 - $56.00
Q4 2024
Shares 1,245,299 Value ($000) $67,433 Avg Close $51.06 Range $45.24 - $58.26
Q3 2024
Shares 1,154,385 Value ($000) $58,204 Avg Close $46.86 Range $39.36 - $55.74
Q2 2024
Shares 1,098,630 Value ($000) $48,307 Avg Close $42.36 Range $37.55 - $50.28
Q1 2024
Shares 510,946 Value ($000) $25,665 Avg Close $54.24 Range $42.43 - $64.98
Q3 2023
Shares 30,451 Value ($000) $1,736 Avg Close $55.20 Range $47.33 - $63.40
Q2 2023
Shares 58,383 Value ($000) $2,978 Avg Close $26.91 Range $17.82 - $55.55
Q1 2022
Shares 653,872 Value ($000) $7,258 Avg Close $9.94 Range $8.90 - $11.96